Why is ogen a strong buy right now

Oragenics, Inc. (OGEN) is currently considered a "Strong Buy" based on the following factors:

1. Analyst Consensus: The current analyst consensus is a "Strong Buy" with a projected target price of $90.00, which is a significant increase from the current trading price. This suggests that analysts believe the stock has potential for growth.
2. Research and Development: OGEN has been actively engaged in research and development, particularly in the area of intranasal vaccines and antibiotics. This indicates a commitment to innovation, which could lead to future revenue streams.
3. Industry Outlook: The biotechnology industry, where OGEN operates, is expected to have high growth due to factors such as the adoption of new therapies and the COVID-19 pandemic. This positive industry outlook can contribute to the stock's potential for growth.
4. Technical Indicators: Despite recent volatility, OGEN has buy signals from both short-term and long-term moving averages, indicating potential for a positive trend. Additionally, the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average, which could be a sign of a pending upward movement.

However, it's important to note that investing in OGEN carries risks, including the company's negative earnings over the last 12 months and the lack of a dividend. Investors should consider their risk tolerance and investment horizon before making a decision.